| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.5M | — |
| R&D Expense | $300.9M | +43.0% |
| SG&A Expense | $79.6M | +15.6% |
| Operating Income | -$373.1M | -33.6% |
| Pre-tax Income | -$344.9M | -44.7% |
| Income Tax | $1.0M | +124.8% |
| Net Income | -$345.9M | -47.6% |
| EPS (Basic) | -$4.36 | -44.9% |
| EPS (Diluted) | -$4.36 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $199.2M | +39.6% |
| Short-term Investments | $349.7M | -27.8% |
| Current Assets | $560.6M | -11.7% |
| Total Assets | $633.2M | -20.7% |
| Current Liabilities | $41.8M | +17.4% |
| Total Liabilities | $51.4M | +18.9% |
| Stockholders' Equity | $581.8M | -22.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$279.1M | -53.9% |
| Capital Expenditures | $799K | -74.0% |
| Investing Cash Flow | $218.0M | +32.1% |
| Financing Cash Flow | $117.1M | +865.5% |
| Free Cash Flow | -$279.9M | -51.7% |
| -44.9% |